Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $105.40 | Total: $527.00 |
| 1 | 10 | $89.28 | Total: $892.80 |
| 1 | 25 | $75.64 | Total: $1,891.00 |
| 1 | 50 | $64.48 | Total: $3,224.00 |
| 1 | 100 | $55.80 | Total: $5,580.00 |
Overview
Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.
Chemical Properties
| Molecular Formula | C12H18N4O2 |
| Molecular Weight | 250.3 |
| CAS Numbers | 66172-75-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(C(CC)C)N1C2=C(C(=O)N(C)C1=O)NC(C)=N2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Young RC Jr, et al. Verofylline, a methylxanthine bronchodilator, in asthma. Clin Pharmacol Ther. 1984 Dec;36[6] 811-6.